rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert Willis

EVP & Chro

Company insider

Files Form 4 as: EVP & Chro, Perrigo Company.

Every Form 4 they filed

In numbers

Trades disclosed
120
Buys
4
Sells
0
Bought
$373K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
15 Aug 2019
Last trade
8 Jul 2026
Last filed
10 Jul 2026

Companies traded

Where they are an officer
PRGO Perrigo CompanyOfficer · Biotechnology · last 8 Jul 20264 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jul 2026filed 10 Jul 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code A—60,085filing
8 Jul 2026filed 10 Jul 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code A—60,085filing
5 Jun 2026filed 8 Jun 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code M$37K3,441 at $10.83filing
5 Jun 2026filed 8 Jun 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code F$19K1,797 at $10.83filing
5 Jun 2026filed 8 Jun 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code M—3,441filing
5 Jun 2026filed 8 Jun 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code M—3,441filing
5 Jun 2026filed 8 Jun 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code M$37K3,441 at $10.83filing
5 Jun 2026filed 8 Jun 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code F$19K1,797 at $10.83filing
13 May 2026filed 15 May 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code A—22,388filing
13 May 2026filed 15 May 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code A—22,388filing
2 Apr 2026filed 3 Apr 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code M$22K2,070 at $10.85filing
2 Apr 2026filed 3 Apr 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code F$12K1,081 at $10.85filing
2 Apr 2026filed 3 Apr 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code M—2,070filing
2 Apr 2026filed 3 Apr 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code M—2,070filing
2 Apr 2026filed 3 Apr 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code M$22K2,070 at $10.85filing
2 Apr 2026filed 3 Apr 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code F$12K1,081 at $10.85filing
6 Mar 2026filed 10 Mar 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code M$29K2,743 at $10.72filing
6 Mar 2026filed 10 Mar 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code F$15K1,430 at $10.72filing
6 Mar 2026filed 10 Mar 2026PRGO Perrigo CompanyBiotechnologySEC FORM 4 Code M$19K1,758 at $10.72filing
6 Mar 2026filed 10 Mar 2026PRGO Perrigo Companyoption or derivative · BiotechnologySEC FORM 4 Code M—2,743filing

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Geoffrey M. ParkerDirector · Director at PERRIGO Co, filing Form 4 there in the last year
Bradley A. AlfordDirector · Director at PERRIGO Co, filing Form 4 there in the last year
David BallEVP & Cbdo · EVP & Cbdo at PERRIGO Co, filing Form 4 there in the last year
Albert ManzoneDirector · Interim President and CEO at PERRIGO Co, filing Form 4 there in the last year
Ahmed Salman AminDirector · Director at PERRIGO Co, filing Form 4 there in the last year
Donald J. TrumpPresident · Also traded PRGO in the last 90 days